[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: U.S. Senate Supports NIH Public Access Policy
- To: <john@arl.org>, <liblicense-l@lists.yale.edu>
- Subject: Re: U.S. Senate Supports NIH Public Access Policy
- From: "Peter Banks" <PBanks@diabetes.org>
- Date: Sun, 17 Jul 2005 18:05:22 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
The Senate language is actually quite a bit more nuanced that this press release suggests. It says: Specifically, the Committee requests that the report contain the following information: 1) the total number of peer reviewed articles deposited in PubMed Central since the May 2nd, 2005 implementation date and the distribution of chosen delay periods; 2) an assessment of the extent to which the implemented policy has led to improved public access; 3) an assessment of the impact of the policy on the peer review system; and 4) the cost of operating the database. The Senate language does not make the assumption that the House committee and OA advocates make: that the number of articles is the sole measure of the success or impact of the policy. Cost and benefit to the taxpayer also matter. It's worth noting that, of the 340 papers submitted, a total of 7 seem to have actually made it online. Much as OA advocates might try to blame poor acceptance on publishers, the poor performance of the NLM in executing this plan may be a bigger factor. Moreover, have any OA advocates actually talked to the researchers who have to take the time to deal with the NIH system? I have. The reaction is pretty much the reaction one gets when confronted with filling out an IRS form or undergoing lengthy dental surgery. From my vanatge point in clinical medicine, it is fantasy to think that researchers are clamoring for this system. Most seem to wish it would just go away so they can get back to what matters: uh, conducting research. I have great respect for Sharon Terry, and share her desire for greater access for information on rare genetic disorders. But to address her comment, if you were a venture capital company, and found that no one wanted your product, the proper solution would be to make the product better or withdraw it, not to try to force your unwilling customers to accept it. Peter Banks Publisher American Diabetes Association 703/299-2033 FAX 703/683-2890 Email: pbanks@diabetes.org >>> john@arl.org 07/15/05 5:49 PM >>> Of possible interest to this list: Alliance for Taxpayer Access www.taxpayeraccess.org For Immediate Release July 15, 2005 U.S. SENATE STRONGLY SUPPORTS NIH PUBLIC ACCESS POLICY Panel Requires NIH to Record and Post Statistics to Judge Effectiveness WASHINGTON, D.C. * One month after the U.S. House of Representatives endorsed the National Institutes of Health (NIH) Public Access policy and called for measures to judge its effectiveness, the U.S. Senate Appropriations Committee followed suit yesterday with language requesting a prompt and thorough report evaluating the success of the policy. "Alliance for Taxpayer Access members are committed to ensuring the implementation of a meaningful public access policy at NIH, and we are encouraged by this strong signal of support from Congress," said Heather Joseph, Executive Director of SPARC (the Scholarly Publishing and Academic Resources Coalition), the founding alliance member. "We are gratified that Members of the Senate Appropriations Committee recognize the important purpose of the NIH public access policy: to speed scientific progress and serve the public. ATA will continue working with the Congressional leadership to ensure the policy's success.� The Senate report accompanying the Fiscal Year 2006 Labor, Health and Human Services, and Education Appropriations bill requests a report from NIH, to be submitted by February 2006, that will include the total number of applicable works submitted since the May 2 implementation date, as well as the embargo period selected by each submitting author. "ATA believes that the NIH policy's success will be measured by the number of articles deposited in PubMed Central and made accessible to the public soon after publication,� said Joseph. �ATA has consistently asked that the NIH provide statistics on the number of papers that are posted on NIH�s PubMed Central repository to help gauge the policy�s effectiveness. We are very pleased that both the Senate and House have requested this critical data from NIH. Moreover, we commend NIH Director Elias Zerhouni for his positive response to ATA�s request to post these critical submission data on the NIH public access website." (To view this document, go to www.taxpayeraccess.com/docs/NIH_Postings_Response.pdf) Data recently released by NIH indicate that the number of submissions since the policy's implementation in early May is very low. Based on annual data, NIH funding is responsible for about 65,000 scholarly articles a year. Therefore, NIH grantees could have chosen to place approximately 11,000 articles on PubMed Central*making this taxpayer-funded research available free to the public. However, statistics provided by NIH this week show that only three percent of this number, or 340 articles accepted for publication, have been submitted by NIH grantees. Sharon F. Terry, President of the Genetic Alliance and a member of the Public Access Working Group, commented that "If we were a venture capital company investing in a new business, and we saw early performance returns at the rate of three percent, we would not wait to re-examine our strategy." The ATA remains a strong advocate for immediate open access to research funded by the NIH. Further information on this issue is available at www.taxpayeraccess.org. ### The Alliance for Taxpayer Access is an informal coalition of stakeholders who support reforms that will make publicly funded biomedical research accessible to the public. The Alliance was formed in 2004 specifically to urge that peer-reviewed articles on taxpayer-funded research at NIH become fully accessible and available online and at no extra cost to the American public. Details on the alliance may be found at www.taxpayeraccess.org. For more information, contact: John D Ignazio, 202-296-2296 x121, john@taxpayeraccess.org
- Prev by Date: Re: A Prophylactic Against the Edentation of the RCUK Policy Proposal
- Next by Date: Re: A Prophylactic Against the Edentation of the RCUK Policy Proposal
- Previous by thread: U.S. Senate Supports NIH Public Access Policy
- Next by thread: Re: A Prophylactic Against the Edentation of the RCUK Policy Proposal
- Index(es):